Ignite Creation Date:
2025-12-24 @ 2:43 PM
Ignite Modification Date:
2026-02-22 @ 7:23 PM
Study NCT ID:
NCT00469859
Status:
COMPLETED
Last Update Posted:
2017-03-15
First Post:
2007-05-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Lestaurtinib, Cytarabine, and Idarubicin in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia
Sponsor:
Children's Oncology Group
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Leukemia | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | recurrent childhood acute myeloid leukemia | View |
| None | adult acute myeloid leukemia with t(16;16)(p13;q22) | View |
| None | adult acute myeloid leukemia with t(8;21)(q22;q22) | View |
| None | adult acute myeloid leukemia with 11q23 (MLL) abnormalities | View |
| None | adult acute myeloid leukemia with inv(16)(p13;q22) | View |
| None | adult acute myeloid leukemia with t(15;17)(q22;q12) | View |
| None | recurrent adult acute myeloid leukemia | View |
| None | secondary acute myeloid leukemia | View |